Article Details

Boston Scientific to sell BTG Specialty Pharmaceuticals for $800M

Retrieved on: 2020-12-01 21:11:15

Tags for this article:

Click the tags to see associated articles and topics

Boston Scientific to sell BTG Specialty Pharmaceuticals for $800M. View article details on hiswai:

Excerpt

SERB, which is backed by <b>Charterhouse Capital Partners</b>, owns a diversified portfolio of prescription medicines focused on rare and life-threatening ...

Article found on: www.massdevice.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo